Accompanying ALZHEIMER CAREGIVER

NCT03994237 | Completed

• 1 other identifier: CHUBX 2016/48
• Study Type: observational
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

Initiatives have been taken hotline in France and abroad for other conditions, they provide support to patients and their caregivers.

Conditions

Alzheimer Disease

Outcome Measures

Primary Outcomes (2)

• score of the grid "MiniZarit"

  The evaluation of the quality of life of the caregiver, score between 0 and 7. point for positive response for difficulties in family life, difficulties in relationships with friends, hobbies, or in your job, a repercussion on health (physical and / or psychological), feeling that caregiver is no longer recognizing his parent, he afraid for the future of his parent, he would like to be (more) helped to take care of his parent, he feel a burden in taking care of his parent.

  Month 1

• score of the EuroQuol scale

  The evaluation of the quality of life of the caregiver The point repartition : Mobility (1 point : to have no problem getting around on foot ; 2 : to have problems getting around on foot; 3. to oblige to remain in bed) Self-sufficiency (1 point : to have no problem taking care of myself; 2 : to have problems washing or dressing myself alone;3 : to be unable to wash or dress myself alone) Regular activities (1 point : to have no problem performing my daily activities (eg work, study, housework, family activities or hobbies) ;2. : to have problems to perform my day-to-day activities;3. : to be unable to perform my normal activities.) Pain / discomfort (1. : to have no pain or discomfort; 2. : to have moderate pain or discomfort (s), 3. : to have severe pain or discomfort (s)) Anxiety / Depression (1. : to be not anxious or depressed; 2. : to be moderately anxious or depressed ;3. : to be extremely anxious or depressed)

  Month 1

Secondary Outcomes (3)

• Number of days between pre-clinical consultation and consultation MEMORY

  Month 3

• Questionnary for caregivers' organization

  Day 1

• Questionnary for caregivers' organization

  Month 1

Study Arms (1)

ALZHEIMER CAREGIVER

Caregiver available to accompany the patient to the consultation, helping calling for the first time the memory center, aidant who noticed a cognitive disorder help, having a family link identified with the patient

Other: semi-structured interview

Interventions

semi-structured interview OTHER

The tool used is a nurse card: there is no validated tool on the expectations of the caregiver in his memory referral. This is a pragmatic and practical questionnaire memory consultation request and domestic life with few items, practical use by telephone.

ALZHEIMER CAREGIVER

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Helping with age ≥ 18 years, speaking and understanding the French and available to accompany the patient to the consultation

You may qualify if:

• Helping with age ≥ 18 years
• Helping speak and understand the French
• Help available to accompany the patient to the consultation
• Helping calling for the first time the memory center
• Helping who noticed a cognitive disorder in assisted
• Age over 75 years
• beneficiary or affiliated to a social security scheme Patient
• Patient with a cognitive disorder noticed by the caregiver

You may not qualify if:

• Helping placed under judicial protection
• Any medical or paramedical personnel in connection with the care of a nursing home eligible patient (Accommodation Establishment for dependent elderly, hospital, SSR (Care and Rehabilitation Services), institutional caregivers,
• private health professionals, such as neighborhood (doctor, nurse liberal, physiotherapist
• Neighborhood.

Sponsors & Collaborators

• University Hospital, Bordeaux: lead

Study Sites (1)

CHU de Bordeaux

Pessac, 33600, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders

Study Officials

• Isabelle GUILLARD

  University of Bordeaux

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 21, 2019
• First Posted: June 21, 2019
• Study Start: December 12, 2018
• Primary Completion: June 7, 2019
• Study Completion: June 7, 2019
• Last Updated: July 1, 2019

Record last verified: 2019-05

Locations

FR (1)